scPharmaceuticals第一季度每股收益$（0.37）低于$（0.30）估计，销售额为1175万美元，超过1163万美元估计

scPharmaceuticals (NASDAQ: SCPH) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.30) by 23.33 percent. This is a 2.78 percent decrease over losses of $(0.36) per share from the same period last year. The company reported quarterly sales of $11.75 million which beat the analyst consensus estimate of $11.63 million by 1.06 percent. This is a 92.59 percent increase over sales of $6.10 million the same period last year.